Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference
August 05 2019 - 9:00AM
Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated
medical technology company with the first and only FDA-approved
swallowable, gas-filled intragastric balloon system for the
treatment of obesity, announces that William Plovanic,
Obalon’s President and Chief Financial Officer, and Bob MacDonald,
the Company’s Chief Retail Officer will present a corporate
overview at the Canaccord Genuity 39th Annual Growth Conference
taking place August 7-8, 2019 in Boston.
Presentation Details:
Date and Time: Thursday, August 8, 2019, 9:00am
ETLocation: InterContinental Hotel, Boston, MAA webcast of the live
presentation will be accessible at
http://wsw.com/webcast/canaccord35/obln/ and will be archived for
90 days following the event.
About Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. (NASDAQ: OBLN) is a San Diego-based
company focused on developing and commercializing novel
technologies for weight loss. For more information, please
visit http://www.obalon.com/.
For Obalon Therapeutics, Inc.
Investor Contact: William Plovanic President and
Chief Financial Officer Obalon Therapeutics, Inc. Office: +1 760
607 5103 wplovanic@obalon.com
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Sep 2023 to Sep 2024